Checkmate Pharmaceuticals, Inc.
CMPIDelisted- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001651431
Checkmate Pharmaceuticals, Inc. was delisted in 2022; its insiders filed their last Form 4 on May 31, 2022; 26 institutions reported holding it in 13F filings for Q1 2022, worth $54.8M in total; no superinvestor held it.
13F holders, Q2 2021
Institutional positions in Checkmate Pharmaceuticals, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 34
- −3 vs. Q1 2021
- Shares held
- 16.3M
- −361.7K (−2.2%) vs. Q1 2021
- Total value
- $97.3M
- −$105.3M (−52.0%) vs. Q1 2021
- New holders
- 9
- 4 more added
- Sold out
- 12
- 11 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CMPI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 26 | $54.8M |
| Q4 2021 | 25 | $46.3M |
| Q3 2021 | 31 | $64.6M |
| Q2 2021 | 34 | $97.3M |
| Q1 2021 | 37 | $202.5M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Checkmate Pharmaceuticals, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| venBio Partners LLC | 3,673,374 | $21.9M | 2.58% | 00.0% | Unchanged |
| Sofinnova Investments, Inc. | 3,606,707 | $21.5M | 1.31% | 00.0% | Unchanged |
| Novo Holdings A/S | 2,170,100 | $12.9M | 0.57% | 00.0% | Unchanged |
| Clough Capital Partners L P | 1,567,326 | $9.34M | 0.52% | +215,013+15.9% | Added |
| Medicxi Ventures Management (Jersey) Ltd | 1,501,716 | $8.95M | 1.60% | 00.0% | Unchanged |
| Omega Fund Management, LLC | 1,335,050 | $7.96M | 0.90% | 00.0% | Unchanged |
| FMR LLC | 966,226 | $5.76M | 0.00% | 00.0% | Unchanged |
| Sectoral Asset Management Inc | 541,766 | $3.23M | 0.26% | 00.0% | Unchanged |
| Vanguard Group Inc | 336,587 | $2.00M | 0.00% | −39,424−10.5% | Reduced |
| Deutsche Bank AG | 134,760 | $803.0K | 0.00% | −3,199−2.3% | Reduced |
| Ensign Peak Advisors, Inc | 119,915 | $714.0K | 0.00% | 00.0% | Unchanged |
| RBF Capital, LLC | 68,834 | $410.0K | 0.02% | +68,834 | New |
| Millennium Management LLC | 40,422 | $241.0K | 0.00% | +40,422 | New |
| Geode Capital Management, LLC | 40,272 | $240.0K | 0.00% | −63,153−61.1% | Reduced |
| Ergoteles LLC | 26,427 | $158.0K | 0.00% | +26,427 | New |
| Alberta Investment Management Corp | 25,000 | $149.0K | 0.00% | +25,000 | New |
| Cambridge Trust Co | 24,609 | $147.0K | 0.01% | 00.0% | Unchanged |
| HRT Financial LP | 24,121 | $143.0K | 0.00% | +24,121 | New |
| Renaissance Technologies LLC | 23,500 | $140.0K | 0.00% | +23,500 | New |
| BlackRock Inc. | 22,850 | $137.0K | 0.00% | −345,376−93.8% | Reduced |
| Bridgeway Capital Management, LLC | 21,500 | $128.0K | 0.00% | −50,015−69.9% | Reduced |
| Federated Hermes, Inc. | 16,169 | $96.0K | 0.00% | −10,781−40.0% | Reduced |
| Advisory Services Network, LLC | 7,800 | $46.0K | 0.00% | +7,800 | New |
| Bank of America Corp | 6,331 | $37.0K | 0.00% | −4,033−38.9% | Reduced |
| JPMorgan Chase & Co | 5,157 | $31.0K | 0.00% | −19,960−79.5% | Reduced |
| The PNC Financial Services Group, Inc. | 5,000 | $30.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 3,296 | $20.0K | 0.00% | +340+11.5% | Added |
| Royal Bank of Canada | 2,387 | $14.0K | 0.00% | +1,364+133.3% | Added |
| US Bancorp | 2,000 | $12.0K | 0.00% | +2,000 | New |
| Morgan Stanley | 392 | $2.00K | 0.00% | +69+21.4% | Added |
| Johnson Midwest Financial, LLC | 200 | $1.00K | 0.00% | +200 | New |
| New York State Common Retirement Fund | 77 | $0 | 0.00% | −4,581−98.3% | Reduced |
| Wells Fargo & Company | 32 | $0 | 0.00% | −2,823−98.9% | Reduced |
| Citigroup Inc | 1 | $0 | 0.00% | −621−99.8% | Reduced |
| State Street Corp | 0 | $0 | 0.00% | −83,259−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −81,359−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −19,300−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −19,146−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −17,188−100.0% | Sold out |
| California State Teachers Retirement System | 0 | $0 | 0.00% | −13,503−100.0% | Sold out |
| Canada Pension Plan Investment Board | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −5,217−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −1,976−100.0% | Sold out |
| Legal & General Group Plc | 0 | $0 | 0.00% | −876−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −608−100.0% | Sold out |
| Ameritas Investment Partners, Inc. | 0 | $0 | 0.00% | −430−100.0% | Sold out |